Skip to main content
. 2023 Nov 21;110(2):956–964. doi: 10.1097/JS9.0000000000000912

Table 2.

Recurrence/progression pattern in LS-SCEC.

Recurrence/progression events CT alone, N (%) CT+RT, N (%) CT+S, N (%) P
Locoregional only 21 (38.9) 30 (27.8) 34 (25.2) 0.3
Distant only 19 (35.2) 54 (50) 66 (48.9)
Both 14 (25.9) 24 (22.2) 35 (25.9)

CT+RT, chemotherapy plus radiotherapy; CT+S, chemotherapy plus surgery; LS-SCEC, limited-stage small cell esophageal carcinoma.